• Text size      
  • Send this article to a friend
  • Print this article

Dark 'is key to cancer treatment'

Total darkness at night could be key to the success of breast cancer therapy, scientists say.

Being exposed to light at night makes breast cancer resistant to the widely used drug tamoxifen, researchers at Tulane University in New Orleans found.

Such exposure shuts off night-time production of the hormone melatonin, and the study suggests this is vital to the success of the drug.

The researchers studied the effect of tamoxifen on human breast-cancer cells implanted in rats. They found melatonin delayed and slowed tumor growth.

But tamoxifen caused "dramatic" regression of tumours in animals with high night-time melatonin during complete darkness or those given melatonin supplements in dim light at night.

Contextual targeting label: 

Commenting & Moderation

We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis.
If you're a relatively new user then your comments will be reviewed before publication and if we know you well and trust you then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules

Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.